Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents

•The continuous development of new oncological treatments have led to the emergence of new neurological side effects.•The neurological side effects of oncological treatments can be life threatening or can impair greatly the quality of life; their management should be performed by specialized teams.•...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revue neurologique Jg. 179; H. 5; S. 405 - 416
Hauptverfasser:	Bompaire, F., Birzu, C., Bihan, K., Desestret, V., Fargeot, G., Farina, A., Joubert, B., Leclercq, D., Nichelli, L., Picca, A., Tafani, C., Weiss, N., Psimaras, D., Ricard, D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	France Elsevier Masson SAS 01.06.2023 Elsevier Masson
Schlagworte:	Antineoplastic Agents - adverse effects Chemotherapy induced polyneuropathy Humans Immune cell effector associated toxicity Immune checkpoint inhibitors Immunotherapy - adverse effects Immunotherapy - methods Life Sciences Myositis Neoplasms - complications Neoplasms - drug therapy Neurotoxicity Syndromes - diagnosis Neurotoxicity Syndromes - etiology Neurotoxicity Syndromes - therapy Radiation induced leukoencephalopathy Radionecrosis Risk Factors RT Radionecrosis CNS HGG Immune checkpoint inhibitors PRN ICI Immune cell effector associated toxicity PNS RIL PRES PD-L1 Myositis CTLA4 Chemotherapy induced polyneuropathy PD-1 Radiation induced leukoencephalopathy NCS
ISSN:	0035-3787
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!